Rupee Gains 45 Paise To Close At 81.24 Against US Dollar
The Indian rupee strengthened on Wednesday, helped by an uptick in most Asian emerging market peers, while traders noted there were some dollar inflows.
The rupee finished the session at 81.24Â per dollar, recovering from trading near its Tuesday's close of 81.76 for the better part of the session. It had declined 0.5% in the first two days of the week.
State-run banks sold dollars on the day, four traders said, but were unsure of the purpose. They also reckoned some bond-related inflows were trickling into the market.
Rupee forward premiums jumped, with 1-year implied yield at a two-month high of 2.35%, with traders again pointing to public sector bank action.
The 81.90-82 band acts as a resistance for the USD/INR pair and we would consider building short positions near that level, said Jigar Trivedi, senior research analyst, currencies and commodities at Reliance Securities.
Options market positioning earlier in the day also signalled a downside in the currency pair.
The dollar index was 0.4% lower, reversing course from earlier in the session after the Bank of Japan maintained its ultra-loose monetary policy, surprising markets. [FRX/]
Asian emerging market currencies rebounded to trade higher, while equities remained buoyant.
India's budget presentation and the Federal Reserve's meeting on Feb. 1 are considered the next big trigger events.
The U.S. central bank's rate decision will be significant for currency markets, with participants expecting a smaller 25-basis-points hike and a terminal rate of around 5%.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.